FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

Similar documents
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

Formulary Updates to DHMP Commercial Plans DHHA: DMC/DMC-HP/POS DHMO/HDHP: City & County of Denver/Denver Police/DERP

FORMULARY ABBREVIATIONS

Step Therapy Approval Criteria

Step Therapy Approval Criteria

2017 Formulary Changes Year to Date

May 2016 P & T Updates

APREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE

Aetna Better Health of Illinois Medicaid Formulary Updates

Kansas Health Advantage (HMO SNP) 2018 Formulary Quantity Limit Criteria

2018 CareOregon Advantage Part D Formulary Changes

Tribute 2018 Formulary 2018 Quantity Limit Criteria

Tribute 2018 Formulary 2018 Quantity Limit Criteria

BLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES

PHARMACY AND THERAPEUTICS COMMITTEE 4 th Quarter 2017

Pharmacy and Therapeutics (P&T) Committee Provider Update

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies

ANTIDIABETIC AGENTS - MISCELLANEOUS

Formulary Updates to DHMP Commercial Plans (POS/DMC/DMC-E/CSA/DERP/DPPA & DHMO:CSA/DERP/DPPA)

Drug Formulary Update, July 2016 Commercial and State Programs

Daclatasvir (Daklinza ) Drug Interactions with HIV Medications

Medicare Part D 2012 Formulary Changes Service To Senior and Total Fit

2018 Formulary Notice of Change Prescription Drug Plans

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTICONVULSANTS. Details

Drug Class Review Monograph GPI Class 12 Antivirals

Peach State Health Plan routinely reviews the medications available on the Preferred Drug

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

Drug Formulary Update, January 2018 Commercial and State Programs

Step Therapy Requirements

Medicare Part D 2017 Formulary Changes OC Preferred

ANTIDIABETIC AGENTS - MISCELLANEOUS

Partners Notice of Change March 2017

Step Therapy Approval Criteria

Pharmacy Medical Necessity Guidelines: Hepatitis C Virus

ANTICONVULSANTS. Details

ALLERGIC CONJUNCTIVITIS AGENTS

Alprazolam 0.25mg, 0.5mg, 1mg tablets

2018 Medicare Part D Formulary Change

NOTIFICATION OF FORMULARY CHANGES

2018 Formulary Update

Pharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017

ANTICONVULSANTS. Details

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

Step Therapy Requirements. Effective: 1/1/2019

JULY 2017 ADDITIONS. NP Thyroid 120mg NP Thyroid 15mg JUNE 2017 CHANGES

ANTICONVULSANTS. Details

Coverage Guideline/Policy & Procedure Status Revision Summary Description

2018 Medicare Part D Formulary Change

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

November 2018 P & T Updates

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

FirstCarolinaCare Insurance Company. Step Therapy Requirements

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

Step Therapy Approval Criteria

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

Emblem Medicaid 3Q18 Formulary Updates

Calgary Long Term Care Formulary

ADDICTION AND RECOVERY TREATMENT SERVICES (ARTS) PROGRAM UPDATE

Medicines Formulary BNF Section 4 Central Nervous System

HIV Drugs and the HIV Lifecycle

Medicare Part D 2017 Formulary Changes Service To Senior

True Health New Mexico List of Medications with Quantity Limits

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Commercial Formulary and Utilization Management Program Updates for January 2017 Producer Communication #782 Issued November 10, 2016

DRUG TREND REPORT. WellDyneRx ANNUAL 1 2% 34% WellDyneRx. Diabetes MS Oncology Asthma/COPD HIV. Pain/inflammation. High Blood Choles Attention Disorde

Capital BlueCross Open/Closed Formulary Update (1 st Quarter 2017)

Quarterly pharmacy formulary change notice

Step Therapy Requirements. Effective: 05/01/2018

Cynthia B. Jones, Director Department of Medical Assistance Services (DMAS)

Pharmacy Updates Summary

Medicare Part D 2017 Formulary Changes OC Preferred

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

PHOTOFRIN Porfimer ALL LOB: ADD NF PA FETZIMA Levomilnacipran 20-40mg Titration pack ALL LOB: Add NF with PA

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary October 1, 2018 Updates. Formulary. Alternatives

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

Medicare Part D 2017 Formulary Changes OC Preferred

Pharmacy and Therapeutics (P&T) Committee Provider Update

Step Therapy Requirements. Effective: 11/01/2018

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

SUPPORTING OUR PROVIDER PARTNERS THROUGH COMMUNICATION AND COLLABORATION. DATE July 2016 ISSUE 3

PATIENT INFORMATION VIREAD

PPHP 2017 Formulary 2017 Step Therapy Criteria

UPDATE Ohana QUEST Integration Medicaid

Guidance for Non-HIV-Specialized Providers Caring for Persons with HIV Displaced by Disasters

Calgary Long Term Care Formulary. Pharmacy & Therapeutics. February 2015

Transcription:

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs during the year. If DHMC/CHP+ removes drugs from the formulary, or adds a restriction to an existing formulary drug, such as prior authorization, quantity limits and/or step therapy, [and/or moves a drug to a higher cost-sharing tier], DHMC/CHP+ will notify you of the change at least 10 days before the date that the change becomes effective. If the Food and Administration (FDA) deems a drug on the formulary to be unsafe, or the drug s manufacturer removes the drug from the market, DHMC/CHP+ will immediately remove the drug from the formulary. The table below outlines previous and/or recent changes to the formulary. The newest updates are highlighted in yellow. For questions or if you would like more information related to these changes please call the DHMC/CHP+ Pharmacy Services Department at 0-60-070 or 877-57-096. FORMULARY ABBREVIATIONS (Explanations can be found on the website in the DHMC/CHP+ Formulary and Pharmaceutical Management Procedures) LA = (must be filled at DH Pharmacy or PA Required); PA = ; QL = ; ST = Ledipasvir/ Sofosbuvir Sofosbuvir/ Velpatasvir Albendazole Estradiol Valerate Vials Lyrica No Updates for th Quarter of 018 Atomoxetine Generic for Harvoni Generic for Epclusa Generic Generic LA, QL, PA 01/01/019 LA, QL, PA 01/01/019 Generic for Generic 1 01/01/019 Albenza Addition Addition 1 01/01/019 ; Gabapentin or Duloxetine LA, QL, ST 01/01/019 10/01/018 Addition Addition LA, QL 07/01/018

Fondaparinux Syringes Buprenorphine/ Naloxone Film 8 mg/ mg Film Praziquantel Atovaquone/ Proguanil Addition Addition Generic Generic for Suboxone 8 mg/ mg Film Generic for Generic Biltricide from to 1; Generic for Norvir Cost LA, QL 07/01/018 LA, QL 07/01/018 LA 07/01/018 1 QL 07/01/018 Ritonavir Generic LA 0/01/018 Tacrolimus Addition Addition LA 0/01/018 Tradjenta Addition Addition LA, QL 0/01/018 Jentadueto Addition Addition LA, QL 0/01/018 Narcan Nasal Addition Addition QL 0/01/018 Spray Buprenorphine Addition Addition LA, QL 0/01/018 Sublingual Estradiol Vaginal Addition Addition 1 QL 0/01/018 Cream Efavirenz Generic for Generic LA 0/01/018 Sustiva Tenofovir Generic for Generic LA 0/01/018 Disoproxil Viread Fumarate Atazanavir Generic for Generic LA 0/01/018 Reyataz Aripiprazole LA, QL 01/01/018 Metformin Cost Metformin LA 01/01/018 (Generic for Fortamet) from 1 to ; Extended- Release (Generic for Glucophage XR) Lyrica Addition Addition LA, QL, PA 01/01/018 Oxycodone Addition Addition One Formulary Long-Acting Opioid LA, QL, ST 01/01/018

Victoza Pens Addition Addition One Formulary Diabetic Medication Priftin Addition Addition Abacavir Oral Generic Generic Solution Ziagen Eletriptan Imiquimod Enoxaparin Generic Relpax from to 1; from to ; Generic Sumatriptan and zolmitriptan LA, QL, ST 01/01/018 LA 01/01/018 LA 10/01/017 LA, QL, ST 10/01/017 1 10/01/017 Mavyret Addition Addition Entresto Addition Addition Risperdal Consta Addition Addition Oral Syringes Risperidone Jardiance Addition Addition One Formulary Diabetic Medication Codeine Products Tramadol Ondansetron and Oral- Disintegrating Norvir Age Updated to 1 Years and Older Age for 1 Years and Older Increased from 0 Per 0 Days to 90 Per 0 Days from to FDA Safety Warning Labeling FDA Safety Warning Labeling QL 10/01/017 LA, QL, PA 10/01/017 LA, QL 07/01/017 LA, QL, ST 07/01/017 LA, QL, ST 07/01/017 Age, QL 07/01/017 Age, QL 07/01/017 QL 07/01/017 LA 07/01/017

Vivitrol Vials Antipyrine/ Benzocaine Otic Solution Atropine Ophthalmic Solution Cytra-K Crystals and Oral Solution Donnatal Elixir and Esterified Estrogens/ Methyltestosterone Hydrocortisone/ Pramoxine Rectal Cream Phenazopyridine Tacrolimus Ointment from 1 to ; Regulatory Requirement Vyvanse Addition Addition Amphetamine Salts and Xarelto 0 mg Venlafaxine Fenofibrate Doxycycline and Duloxetine LA, QL 07/01/017 LA 07/01/017 Addition Addition Topical Corticosteroids LA, QL, ST 0/01/017 LA, QL, ST 0/01/017 or Methylphenidate LA, QL 0/01/017 Increased Increased and from to 1 Cost QL 0/01/017 QL 0/01/017 QL 0/01/017 1 QL 0/01/017

Aranesp Syringes and Vials Leukine Syringes and Vials Neupogen Syringes and Vials Epinephrine Auto- Injectors Generic Epipen and Epipen Jr LA 01/01/017 LA 01/01/017 LA 01/01/017 Generic 1 QL 01/01/017 Descovy Addition Addition LA 01/01/017 Genvoya Addition Addition LA 01/01/017 Odefsey Addition Addition LA 01/01/017 Vemlidy Addition Addition LA 01/01/017 Vivitrol Vials Addition Addition LA, QL, PA 01/01/017 Oseltamivir Generic Tamiflu Generic 1 QL 01/01/017 Abacavir/ Lamivudine Aripiprazole Lidocaine 5% Ointment Generic Epzicom ; from 1 to and Limited Access and Generic Cost Clozapine, Olanzapine, Quetipaine, Risperidone, Ziprasidone Lidocaine % Cream LA 01/01/017 LA, QL, PA 01/01/017 LA, QL 01/01/017

Sovaldi Deletion Cost Epclusa, Harvoni, Zepatier 01/01/017 Epclusa Addition Addition LA, PA, QL 10/01/016 Zepatier Addition Addition LA, PA, QL 10/01/016 Mesalamine Generic Generic 10/01/016 Delayed-Release Asacol HD Colchicine Addition Addition LA, QL, ST 10/01/016 Guanfacine Acitretin Rosuvastatin ; Generic Crestor LA, QL 10/01/016 Methotrexate LA, ST 10/01/016 Generic LA, QL 07/01/016 Modafinil Addition Addition QL 07/01/016 Complera Addition Addition LA 07/01/016 Celecoxib QL 07/01/016 Diclofenac Gel Generic Voltaren Gel Generic 1 QL 07/01/016 Levitra Age QL 07/01/016